CD79A and type 1 diabetes mellitus: Our analysis revealed that overexpression of DLD activated glycosaminoglycan degradation, galactose metabolism, hematopoietic cell lineage, intestinal immune network for IgA production, Leishmania infection, type I diabetes mellitus, base excision repair, and other pathways.